Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy
ContributorsPagnoux, Christian; Quéméneur, Thomas; Ninet, Jacques; Diot, Elisabeth; Kyndt, Xavier; de Wazières, Benoît; Reny, Jean-Luc
; Puéchal, Xavier; le Berruyer, Pierre-Yves; Lidove, Olivier; Vanhille, Philippe; Godmer, Pascal; Fain, Olivier; Blockmans, Daniel; Bienvenu, Boris; Rollot, Florence; Aït el Ghaz-Poignant, Séverine; Mahr, Alfred; Cohen, Pascal; Mouthon, Luc; Perrodeau, Elodie; Ravaud, Philippe; Guillevin, Loïc; French Vasculitis Study Group
Published inArthritis & rheumatology, vol. 67, no. 4, p. 1117-1127
Publication date2015
Abstract
Keywords
- Adrenal Cortex Hormones/therapeutic use
- Aged
- Aged, 80 and over
- Azathioprine/therapeutic use
- Cyclophosphamide/therapeutic use
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Male
- Methotrexate/therapeutic use
- Remission Induction/methods
- Systemic Vasculitis/drug therapy
- Treatment Outcome
Affiliation entities
Research groups
Citation (ISO format)
PAGNOUX, Christian et al. Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy. In: Arthritis & rheumatology, 2015, vol. 67, n° 4, p. 1117–1127. doi: 10.1002/art.39011
Main files (1)
Article (Published version)
Identifiers
- PID : unige:79659
- DOI : 10.1002/art.39011
- PMID : 25693055
Journal ISSN2326-5191
